On-Demand CME Videos
Therapeutic Options in Vitiligo Treatment: An Evolving Landscape: An Online Activity
About
Therapeutic Options in Vitiligo Treatment: An Evolving Landscape: An Online Activity
This activity is supported by an educational grant from Incyte.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
March 28, 2024
April 1, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Describe the role of emerging therapies for the treatment and management of vitiligo.
Describe strategies to individualize care when using emerging therapies for vitiligo.
Identify techniques for incorporating emerging vitiligo therapies into everyday practice.
Intended Audience
Faculty
Seemal Desai, MD
Clinical Assistant Professor
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX
Heather Woolery-Lloyd, MD
Director, Skin of Color Division
Dr Phillip Frost Department of Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine
Miami, Florida
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: AbbVie, Incyte, Dermavant, AOBiome,
Consultant: Galderma, Almirall, Ferndale, BMS, AbbVie, Verrica, UCB, Ortho, Scientis, EPI, Avita, Eli Lilly, Leo, Pfizer, Incyte, L’Oreal, Beiersdorf, J&J
Speakers’ Bureau or Honoraria: Dermavant, Galderma, Pfizer
Advisory Board: Incyte, Ortho Dermatologics, Allergan, Arcutis
Grant/Research Support: Allergan, Galderma, Eirion, Arcutis
Speakers Bureau or Honoraria: Incyte, Ortho Dermatologics, Lilly
Ownership Interest (privately held): DermFriends
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.